Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery

Annals of Thoracic Surgery

Volumn 86, Issue 5, 2008, Pages 1431-1437

  Halkos, Michael E ^a   Lattouf, Omar M ^a   Puskas, John D ^a   Kilgo, Patrick ^a   Cooper, William A ^a   Morris, Cullen D ^a   Guyton, Robert A ^a   Thourani, Vinod H ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CHRONIC LUNG DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS SURGERY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLYCEMIC CONTROL; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURVIVAL;

CARDIOVASCULAR DISEASES; COMORBIDITY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 53849112657     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.06.078     Document Type: Article

References (21)

1. The BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 35 (2000) 1122-1129
2. Carson J.L., Scholz P.M., Chen A.Y., Petersen E.D., Gold J., and Schneider S.H. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 40 (2002) 418-423
3. Thourani V.H., Weintraub W.S., Stein B., et al. Influence of diabetes mellitus on early and late outcomes after coronary artery bypass grafting. Ann Thorac Surg 67 (1999) 1045-1052
4. Calafiore A.M., Di Mauro M., Di Giammarco G., et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg 125 (2003) 144-154
5. Furnary A.P., and Wu Y. Eliminating the diabetic disadvantage: the Portland Diabetic Project. Semin Thorac Cardiovasc Surg 18 (2006) 302-308
6. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1007-1021
7. Rajakaruna C., Rogers C.A., Suranimala C., Angelini G.D., and Ascione R. The effect of diabetes mellitus on patients undergoing coronary surgery: a risk adjusted analysis. J Thorac Cardiovasc Surg 132 (2006) 802-810
8. Barsness G.W., Peterson E.D., Ohman E.M., et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 96 (1997) 2551-2556
9. Mohammadi S., Dagenais F., Mathieu P., et al. Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery. Circulation 116 Suppl 1 (2007) 220-225
10. Leavitt B.J., Sheppard L., Maloney C., et al. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation 110 (2004) 41-44
11. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
12. UK Prospective Diabetes Study (UKPDS) group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
13. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 28 Suppl (2005) 4-36
14. Halkos M.E., Puskas J.D., Lattouf O.M., et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 136 (2008) 631-640
15. Schisterman E.F., and Whitcomb B.W. Use of the Social Security Administration Death Master File for ascertainment of mortality status. Popul Health Metr 2 (2004) 2
16. Hammoud T., Tanguay J.F., and Bourassa M.G. Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 36 (2000) 355-365
17. Woods S.E., Smith J.M., Sohail S., Sarah A., and Engle A. The influence of type 2 diabetes mellitus in patients undergoing coronary artery bypass graft surgery. Chest 126 (2004) 1789-1795
18. Furnary A.P., Zerr K.J., Grunkemeier G.L., and Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67 (1999) 352-362
19. Ono T., Kobayashi J., Sasako Y., et al. The impact of diabetic retinopathy on long-term outcome following coronary artery bypass graft surgery. J Am Coll Cardiol 40 (2002) 428-436
20. Nathan D.M., Buse J.B., Davidson M.B., et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 29 (2006) 1963-1972
21. Saudek C.D., Derr R.L., and Kalyani R.R. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 295 (2006) 1688-1697